Disseminated and localised herpes zoster following Oxford-AstraZeneca COVID-19 vaccination.

Jiang, Zi-Han; Wong, Lai-San; Lee, Chih-Hung; Hsu, Ting-Jung; Yu, Yi-Hsiang

Jiang, Zi-Han; Wong, Lai-San; Lee, Chih-Hung; Hsu, Ting-Jung; Yu, Yi-Hsiang.

Jiang ZH; Department of Dermatology, Chang Gung Memorial Hospital - Kaohsiung Medical Center, Kaohsiung, Taiwan.
Wong LS; Department of Dermatology, Chang Gung Memorial Hospital - Kaohsiung Medical Center, Kaohsiung, Taiwan.
Lee CH; Department of Dermatology, Chang Gung Memorial Hospital - Kaohsiung Medical Center, Kaohsiung, Taiwan.
Hsu TJ; Department of Dermatology, Chang Gung Memorial Hospital - Kaohsiung Medical Center, Kaohsiung, Taiwan.
Yu YH; Department of Dermatology, Chang Gung Memorial Hospital - Kaohsiung Medical Center, Kaohsiung, Taiwan.

Indian J Dermatol Venereol Leprol ; 88(3): 445, 2022.

Article in English | MEDLINE | ID: covidwho-1780414

Subject(s)

COVID-19; ChAdOx1 nCoV-19; Herpes Zoster; COVID-19/prevention & control; ChAdOx1 nCoV-19/adverse effects; Herpes Zoster/chemically induced; Herpes Zoster/diagnosis; Herpesvirus 3, Human; Humans; Vaccination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / ChAdOx1 nCoV-19 / Herpes Zoster Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Indian J Dermatol Venereol Leprol Year: 2022 Document Type: Article Affiliation country: IJDVL_819_2021

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google